SAAVE, NCT01432106: The Study of Novel Dual Renin Angiotensin Aldosterone System (RAAS) Blockade; Valsartan/Aliskiren in African American Patients With Hypertension and the Metabolic Syndrome |
|
|
| Withdrawn | 1 | 0 | US | Aliskerin/Valsartan and Rampiril, Tekturna (Aliskerin), Diovan (Valsartan), Valturna (Aliskerin/Valsartan, Altace (Ramipril) | University of Michigan, Novartis Pharmaceuticals | Hypertension, Metabolic Syndrome | 12/12 | 12/12 | | |
